Vanda Pharmaceuticals Inc (VNDA)
Net Income Growth
-310.61%
TTM · Period ending:
VNDA Net Income Growth
Year-over-year change vs the same period a year earlier
Latest reported-310.61%period ending
Latest reported-310.61%period ending
VNDA TTM Net Income YoY % (-165.91% → -310.61%)
Year-over-year change
High-resolution chart · PNG
VNDA net income growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | Net Income Growth |
|---|---|
| -310.6145% | |
| -441.3736% | |
| -1,066.5291% | |
| -413.7845% | |
| -512.5835% | |
| -805.0522% | |
| -853.2882% | |
| -239.2353% | |
| -173.3208% | |
| -130.6386% | |
| -60.0159% | |
| 81.3001% | |
| 35.5681% | |
| -11.7032% | |
| -81.072% | |
| -81.053% | |
| -66.1128% | |
| -42.6304% | |
| 42.0577% | |
| 76.9561% | |
| -71.5036% | |
| -72.9955% | |
| -79.8041% | |
| -84.0892% | |
| 300.2074% | |
| 441.8068% | |
| 358.3981% | |
| 835.4112% | |
| 2,106.7494% | |
| 543.369% | |
| 261.9323% | |
| 190.7696% | |
| 112.6212% | |
| 63.4805% | |
| 13.5647% | |
| 55.4931% | |
| 75.2322% | |
| 68.3427% | |
| 54.8237% | |
| -172.1238% | |
| -178.2656% | |
| -215.0862% | |
| -297.5031% | |
| 178.1199% | |
| 186.2136% | |
| 185.6436% | |
| 199.6544% | |
| -200.8105% | |
| -222.5365% | |
| -78.4921% | |
| 26.7821% | |
| 29.1483% | |
| 22.8731% | |
| -33.3799% | |
| -182.2281% | |
| -1,189.2104% | |
| -687.9433% | |
| -363.2881% | |
| -236.2903% | |
| 50.9875% | |
| 127.5721% | |
| 123.5855% | |
| 120.0564% | |
| 87.563% | |
| 59.3391% | |
| 24.879% | |
| 29.777% | |
| 46.9348% | |
| 50.56% | |
| 50.7248% | |
| 31.0592% | |
| 1.3864% | |
| -36.0864% | |
| -28.1197% | |
| -16.6247% | |
| -11.5443% | |
| -6.4351% | |
| -68.1864% | |
| -165.9118% |